MLN3651 treatment of Merlin-deficient grade I meningioma for 24 hours led to an increase in pERK1/2 expression, suggesting that Raf/MEK/ERK is activated in response to MLN3651 (Figure 4A). This evidence concerns the gene RAF1 and meningioma.